
QUB Blood Cancer Research
@qubbloodcancer
Exploring the molecular biology of a number of blood cancers and identifying potential new and repurposed therapies to target these cancers.
ID: 1310868210372272128
29-09-2020 09:05:29
550 Tweet
343 Followers
100 Following







Mary Frances McMullin discussing management of erythrocytosis and PV. Important to individualise management especially for those with secondary erythrocytosis BSH - Haematology #BSH2025


📢 Carreras Leaders's 4th call is OPEN —join our fight against blood cancers! Apply by June 1, 2025 at carrerasleaders.eu 🔬World-class researchers supervision 🌍International secondments ⭐️Top-tier research infrastructures Marie Skłodowska-Curie Actions European Commission





Join me and Dr David Palmer, Haematology Clinician at University Hospitals Sussex BSMS, for a 3.5 year Sussex Life Sciences funded PhD (UK home fees only) studying RUNX1 mutations in myeloid leukaemia here at University of Sussex Sussex Blood Cancer Research Sussex Cancer Research Centre Details and apply👇👇 sussex.ac.uk/study/fees-fun…

As Myeloma Awareness Week continues we wanted to share some information on the myeloma research that Leukaemia & Lymphoma NI is funding in the The Patrick G Johnston Centre for Cancer Research #MyelomaAwarenessWeek2025 #MultipleMyeloma #MyelomaResearch


Congratulations to our #Omani colleague, Dr Maryam Al Barashdi, a previous QUB Blood Cancer Research PhD student, on her new publication mjournal.squ.edu.om/home/vol25/iss…



Just published by Lappin Lab (PGJCCR | QUB) QUB Blood Cancer Research - BV-6 represents a therapeutic opportunity for SF3B1 mutant cancers. Leukaemia&LymphomaNI Leukaemia UK Cancer Research UK nature.com/articles/s4141…


📍 We’ve just launched our 23rd UK Hospital Hub in Belfast! 🙌 In partnership with Leukaemia&LymphomaNI and thanks to The National Lottery Community Fund NI, LC Navigator Susanne is now on hand weekly to support leukaemia patients & families across Northern Ireland. Find out more about our Hospital Hubs here


We recently said a fond farewell to Dr Jonathan Morgan as he leaves the Blood Cancer group at The Johnston Cancer Research Centre and heads off to study medicine. We took a few minutes to ask Jonathan to reflect on his 8 years working in blood cancer research and on being supported by LLNI.